| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | CMO & CHIEF SCIENTIFIC OFFICER | Ordinary Shares | 656K | $1.02M | $1.55 | 31 Jan 2024 | Direct |
| Gamida Cell Ltd. | CMO & CHIEF SCIENTIFIC OFFICER | Employee Share Option (Right to Buy) | 116K | 08 Feb 2023 | Direct | ||
| Clovis Oncology, Inc. | Director | Stock Option (right to buy) | 83.2K | 12 Jul 2021 | Direct | ||
| Tempest Therapeutics, Inc. | Director | Stock Option (right to buy) | 16K | 13 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 18:05 |
| GMDA | Gamida Cell Ltd. | 31 Jan 2024 | 1 | $0 | 4 | CMO & CHIEF SCIENTIFIC OFFICER | 02 Feb 2024, 16:40 |
| TPST | Tempest Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:46 |
| GMDA | Gamida Cell Ltd. | 08 Feb 2023 | 2 | $0 | 4 | CMO & Chief Scientific Officer | 10 Feb 2023, 18:59 |
| GMDA | Gamida Cell Ltd. | 15 Nov 2022 | 0 | $0 | 3 | CMO & Chief Scientific Officer | 10 Feb 2023, 18:49 |
| TPST | Tempest Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 16:11 |
| TPST | Tempest Therapeutics, Inc. | 06 Aug 2021 | 1 | $0 | 4 | Director | 10 Aug 2021, 19:05 |
| TPST | Tempest Therapeutics, Inc. | 06 Aug 2021 | 0 | $0 | 3 | Director | 10 Aug 2021, 19:01 |
| CLVS | Clovis Oncology, Inc. | 12 Jul 2021 | 1 | $0 | 4 | Director | 13 Jul 2021, 16:25 |
| CLVS | Clovis Oncology, Inc. | 12 Jul 2021 | 0 | $0 | 3 | Director | 13 Jul 2021, 16:23 |